BRCA1- and BRCA2-deficient breast cancers from WSI and TCGA had significantly higher proportion of homologous recombination repair deficient mutational signature (signature 3 as per nomenclature by Alexandrov et al. [38]). This evidence concerns the gene BRCA1 and breast cancer.